Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

Petri Bono; Stephane Oudard; Istvan Bodrogi; Thomas E. Hutson; Bernard Escudier; Jean-Pascal Machiels; John A. Thompson; Robert A. Figlin; Alain Ravaud; Mert Basaran; Camillo Porta; Sergio Bracarda; Thomas Brechenmacher; Chinjune Lin; Maurizio Voi; Viktor Grunwald; Robert J. Motzer

doi:10.1016/j.clgc.2016.04.011

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

Petri Bono, Stephane Oudard, Istvan Bodrogi, Thomas E. Hutson, Bernard Escudier, Jean-Pascal Machiels, John A. Thompson, Robert A. Figlin, Alain Ravaud, Mert Basaran, Camillo Porta, Sergio Bracarda, Thomas Brechenmacher, Chinjune Lin, Maurizio Voi, Viktor Grunwald, Robert J. Motzer

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Clinical Genitourinary Cancer
Vuosikerta	14
Numero	5
Sivut	406-414
Sivumäärä	9
ISSN	1558-7673
DOI - pysyväislinkit	https://doi.org/10.1016/j.clgc.2016.04.011
Tila	Julkaistu - lokakuuta 2016
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1016/j.clgc.2016.04.011

Outcomes in Patients With Metastatic Renal Cell CarcinomaLopullinen julkaistu versio, 694 KBLisenssi: CC BY

Siteeraa tätä

Bono, P., Oudard, S., Bodrogi, I., Hutson, T. E., Escudier, B., Machiels, J-P., Thompson, J. A., Figlin, R. A., Ravaud, A., Basaran, M., Porta, C., Bracarda, S., Brechenmacher, T., Lin, C., Voi, M., Grunwald, V., & Motzer, R. J. (2016). Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials. Clinical Genitourinary Cancer, 14(5), 406-414. https://doi.org/10.1016/j.clgc.2016.04.011

Bono, Petri ; Oudard, Stephane ; Bodrogi, Istvan ; Hutson, Thomas E. ; Escudier, Bernard ; Machiels, Jean-Pascal ; Thompson, John A. ; Figlin, Robert A. ; Ravaud, Alain ; Basaran, Mert ; Porta, Camillo ; Bracarda, Sergio ; Brechenmacher, Thomas ; Lin, Chinjune ; Voi, Maurizio ; Grunwald, Viktor ; Motzer, Robert J. / Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia : Combined Subgroup Analyses of the RECORD-1 and REACT Trials. Julkaisussa: Clinical Genitourinary Cancer. 2016 ; Vuosikerta 14, Nro 5. Sivut 406-414.

@article{387f3183ae8e422f8b1670103f01fefa,

title = "Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials",

keywords = "Class effects of mTOR inhibition, Association of AEs and clinical efficacy, Targeted therapy, mTOR inhibitor, EXPANDED-ACCESS PROGRAM, BLOOD-PRESSURE, PHASE-II, HYPERTENSION, MANAGEMENT, SUNITINIB, EFFICACY, BIOMARKER, THERAPIES, PATHWAY, 3122 Cancers",

author = "Petri Bono and Stephane Oudard and Istvan Bodrogi and Hutson, {Thomas E.} and Bernard Escudier and Jean-Pascal Machiels and Thompson, {John A.} and Figlin, {Robert A.} and Alain Ravaud and Mert Basaran and Camillo Porta and Sergio Bracarda and Thomas Brechenmacher and Chinjune Lin and Maurizio Voi and Viktor Grunwald and Motzer, {Robert J.}",

year = "2016",

month = oct,

doi = "10.1016/j.clgc.2016.04.011",

language = "English",

volume = "14",

pages = "406--414",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "CIG MEDIA GROUP, LP",

number = "5",

}

Bono, P, Oudard, S, Bodrogi, I, Hutson, TE, Escudier, B, Machiels, J-P, Thompson, JA, Figlin, RA, Ravaud, A, Basaran, M, Porta, C, Bracarda, S, Brechenmacher, T, Lin, C, Voi, M, Grunwald, V & Motzer, RJ 2016, 'Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials', Clinical Genitourinary Cancer, Vuosikerta 14, Nro 5, Sivut 406-414. https://doi.org/10.1016/j.clgc.2016.04.011

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia : Combined Subgroup Analyses of the RECORD-1 and REACT Trials. / Bono, Petri; Oudard, Stephane; Bodrogi, Istvan; Hutson, Thomas E.; Escudier, Bernard; Machiels, Jean-Pascal; Thompson, John A.; Figlin, Robert A.; Ravaud, Alain; Basaran, Mert; Porta, Camillo; Bracarda, Sergio; Brechenmacher, Thomas; Lin, Chinjune; Voi, Maurizio; Grunwald, Viktor; Motzer, Robert J.

julkaisussa: Clinical Genitourinary Cancer, Vuosikerta 14, Nro 5, 10.2016, s. 406-414.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia

T2 - Combined Subgroup Analyses of the RECORD-1 and REACT Trials

AU - Bono, Petri

AU - Oudard, Stephane

AU - Bodrogi, Istvan

AU - Hutson, Thomas E.

AU - Escudier, Bernard

AU - Machiels, Jean-Pascal

AU - Thompson, John A.

AU - Figlin, Robert A.

AU - Ravaud, Alain

AU - Basaran, Mert

AU - Porta, Camillo

AU - Bracarda, Sergio

AU - Brechenmacher, Thomas

AU - Lin, Chinjune

AU - Voi, Maurizio

AU - Grunwald, Viktor

AU - Motzer, Robert J.

PY - 2016/10

Y1 - 2016/10

KW - Class effects of mTOR inhibition

KW - Association of AEs and clinical efficacy

KW - Targeted therapy

KW - mTOR inhibitor

KW - EXPANDED-ACCESS PROGRAM

KW - BLOOD-PRESSURE

KW - PHASE-II

KW - HYPERTENSION

KW - MANAGEMENT

KW - SUNITINIB

KW - EFFICACY

KW - BIOMARKER

KW - THERAPIES

KW - PATHWAY

KW - 3122 Cancers

U2 - 10.1016/j.clgc.2016.04.011

DO - 10.1016/j.clgc.2016.04.011

M3 - Article

VL - 14

SP - 406

EP - 414

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 5

ER -